The potential role of cardiac resynchronization therapy in acute heart failure syndromes

Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, For the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2009) Heart disease and stroke statistics–2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 119:e21–e181 Braunwald E (1997) Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369 Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Pieper K, Sun JL, Yancy C, Young JB, For the OPTIMIZE-HF Investigators and Hospitals (2007) Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 297:61–70 Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB, For the OPTIMIZE-HF Investigators and Hospitals (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50:768–777 Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, Hernandez AF (2008) Early and long-term outcomes of heart failure in elderly persons, 2001–2005. Arch Intern Med 168(22):2481–2488 Fonarow GC (2008) Epidemiology and risk stratification in acute heart failure. Am Heart J 155:200–207 Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC Jr, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M, For the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators (2008) Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 299:2656–2666 Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, For the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators (2004) Cardiac: resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150 Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, For the Cardiac Resynchronization–Heart Failure (CARE-HF) Study Investigations (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549 Moss AJ, Hall WJ, Cannon DS, Klein H, Brown MW, Daubert JP, Estes NAM III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, For the MADIT-CRT Trial Investigators (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338 Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, For the Resynchronization-Defibrillation for Ambulatory Heart Failure (RAFT) Investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395 Ujeyl A, Stevenson LW (2009) Populations for CRT devices. Heart Rhythm 6:1373–1377 Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow GC, For the Get With the Guidelines Steering Committee and Hospitals (2008) Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 118:926–933 Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN, Fonarow GC (2009) Cardiac resynchonization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J 158:956–964 Beshai JF, Grimm RA, Nagueh SF, Baker JH II, Beau SL, Greenberg SM, Pires LA, Tchou PJ, For the RethinQ Study Investigators (2007) Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 357:2461–2471 Chung ES, Leon AR, Tavazzi L, Sun J-P, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu C-M, Gorcsan J III, John Sutton M, De Sutter J, Murillo J (2008) Results of the predictors of response to CRT (PROSPECT) Trial. Circulation 117:2608–2616 Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). American college of cardiology web site. Available at http://www.acc.org/clinical/guidelines/failure//index.pdf Ammar KA, Jacobsent SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, Rodeheffer RJ (2007) Prevalence and prognostic significance of heart failure stages: application of the American college of cardiology/American heart association heart failure staging criteria in the community. Circulation 115:1563–1570 Bhattacharya S, Abebe K, Simon M, Saba S, Adelstein E (2010) Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy. J Cardiac Fail 16:931–937 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices). J Am Coll Cardiol 51:e1–e62 Cleland JGF, Goode K, Khaleva O, Khan N (2006) How many patients need cardiac resynchronization therapy? Eur Heart J 27:251–252 Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M (2007) Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York heart association class IV heart failure. Circulation 115:204–212 Tang WHW, Francis GS (2007) Cardiac resynchronization therapy in New York heart association class IV heart failure: it is all about selection. Circulation 115:161–162 Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW (2000) Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140:840–847 Solomon SD, Dobson J, Pocock S, Skali H, McMurrat JJV, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, For the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116:1482–1487 Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med 360:1418–1428 Fonarow GC, Peterson ED (2009) Heart failure performance measures and outcomes: real or illusory gains. JAMA 302:792–794 Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O’Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, Bristow MR (2009) Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. Circulation 119:969–977 Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M, Douglas MR, Berger RD, McVeigh ER, Kass DA (2000) Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 101:2703–2709 Kass DA, Chen C-H, Curry C, Talbot M, Berger R, Fetics B, Nevo E (1999) Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 99:1567–1573 Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA (2000) Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102:3053–3059 Waggoner AD, Faddis MN, Gleva MJ, de Las Fuentes L, Osborn J, Heuerman S, Davila-Roman VG (2005) Cardiac resynchronization therapy acutely improves diastolic function. J Am Soc Echocardiogr 18:216–220 Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C (2003) Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41:765–770 Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J III (2004) A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 44:1619–1625 Birnie DH, Tang ASL (2006) The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 21:20–26 Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS (2007) Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Am J Cardiol 100:90–93 James KB, Militello M, Gus B, Wilkoff BL (2006) Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases. Tex Heart Inst J 33:19–22 Konstantino Y, Iakobishvili Z, Arad O, Beg-Gal T, Kusniec J, Mazur A, Porter A, Strasberg B, Battler A, Hasdai D (2006) Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. Cardiology 106:59–62 Cowburn PJ, Patel H, Jolliffe RE, Wald RW, Parker JD (2005) Cardiac resynchronization therapy: an option for inotropic-supported patients with end-stage heart failure? Eur J Heart Fail 7:215–217 Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L, For the International Working Group on Acute Heart Failure Syndromes (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112:3958–3968 Gheorghiade M, Pang PS (2009) Acute heart failure syndromes. J Am Coll Cardiol 53:557–573 Expanded indications for Boston scientific’s CRT-D devices based on MADIT-CRT study FDA review of P010012/S230. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM205849.pdf. Accessed 7 Apr 2010 Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Messenger J, For the MIRACLE Study Group (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853 Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, For The Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 289:2685–2694 Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG (2003) Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42:1454–1459 Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert J-C, For the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880 León AR, Abraham WT, Brozena S, Daubert JP, Fisher WG, Gurley JC, Liang CS, Wong G, For the InSync III Clinical Study Investigators (2005) Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate: severe heart failure. J Am Coll Cardiol 46:2298–2304 Linde C, Abraham WT, Gold MR, John Sutton M, Ghio S, Daubert C, On behalf of the Reverse (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Study Group (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843 Sauer WH, Bristow MR (2008) The comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial in perspective. J Interv Card Electrophysiol 21:3–11 Gras D, Böcker D, Lunati M, Wellens HJJ, Calvert M, Freemantle N, Gervais R, Kappenberger L, Tavazzi L, Erdmann E, Cleland JGF, Daubert J-C, On behalf of The CARE-HF Study steering committee and investigators (2007) Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 9:516–522 León AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, Hayes DL, Lieberman R, Petersen-Stejskal S, Wheelan K, For the MIRACLE Study Program (2005) Safety of transvensou cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 46:2348–2356 Cowburn PJ, Patel H, Pipes RR, Parker JD (2005) Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity. Eur J Heart Fail 7:899–903 Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S, For the PEOPLE Study Group (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116:1349–1355 Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017 Wang NC, Piccini JP, Konstam MA, Maggioni AP, Traver B, Swedberg K, Udelson JE, Zannad F, Cook T, O’Connor CM, Miller AB, Grinfeld L, Gheorghiade M, For the EVEREST Investigators (2010) Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction. Am J Ther 17:e78–e87